title: Preventive efficacy of Frontline® Combo and Certifect® against Dipylidium caninum infestation of cats and dogs using a natural flea (Ctenocephalides felis) infestation model.
abstract: Two studies were performed to evaluate the effectiveness of two monthly topical anti-flea products for the prevention of Dipylidium caninum infestations in cats and dogs. A single treatment with Frontline(®) Combo spot-on for cats (fipronil-(S)-methoprene) and two successive monthly treatments of Certifect(®) for dogs (fipronil-amitraz-(S)-methoprene) were assessed for the prevention of D. caninum infestations following weekly challenges of treated cats or dogs with metacestode naturally-infected fleas. The rate of infestations using the model in cats versus dogs explains the choice of a 1-month trial in cats and a 2-month trial in dogs. The experimental flea-infection model resulted in a range of 22-53% of the fleas being infected by Dipylidium cysticercoids. The arithmetic mean flea counts recorded for the untreated cats ranged from 51.2 to 68. The geometric mean flea counts recorded for the Frontline Combo treated cats differed significantly (p < 0.05) from those of the untreated control cats on all assessment days. The arithmetic mean flea counts recorded for the untreated dogs ranged from 166.6 to 238.6. The geometric mean flea counts recorded for the Certifect treated dogs differed significantly (p < 0.001) from those of the untreated group on all assessment days. Frontline Combo treatment on cats provided ≥99.8% persistent anti-flea efficacy throughout the 30-day treatment period. In the dog study, the two Certifect treatments provided ≥97% persistent efficacy throughout the 60-day study. Based on the collection of expelled D. caninum proglottids by cats, 100% (6/6) of the control cats and 0% (0/6) of Frontline Combo treated cats were infested with D. caninum. Frontline Combo spot-on for cats was therefore 100% effective in preventing infection with D. caninum. In dogs, 7 out of the 8 control group dogs (87.5%) produced proglottids following infestation of infected fleas, whereas 0 out of 8 dogs (0%) in the treated group were infected. The infection rates of the two groups were significantly different. The percent effectiveness for the Certifect treatment group for the prevention of D. caninum infection was 100% during this 2-month trial. No treatment-related adverse events were observed in either cats or dogs during these studies.
authors: Merial, 29 Av T. Garnier, 69007 Lyon, France.
authors: Frederic
authors: F
authors: Beugnet
authors: Peet
authors: P
authors: Delport
authors: Hermann
authors: H
authors: Luus
authors: Dione
authors: D
authors: Crafford
authors: Josephus
authors: J
authors: Fourie
mesh_terms: D000287:Administration, Topical; D000818:Animals; D002371:Cat Diseases / Q000469:parasitology / Q000517:prevention & control*; D002415:Cats; D002590:Cestode Infections / Q000150:complications / Q000469:parasitology / Q000517:prevention & control / Q000662:veterinary*; D004283:Dog Diseases / Q000469:parasitology / Q000517:prevention & control*; D004285:Dogs; D004338:Drug Combinations; D005243:Feces / Q000469:parasitology; D005260:Female; D058267:Flea Infestations / Q000150:complications / Q000469:parasitology / Q000517:prevention & control / Q000662:veterinary*; D007306:Insecticides / Q000008:administration & dosage*; D008297:Male; D008726:Methoprene / Q000008:administration & dosage; D011720:Pyrazoles / Q000008:administration & dosage; D014052:Toluidines / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; D007306:Insecticides; D011720:Pyrazoles; D014052:Toluidines; C014983:amitraz; D008726:Methoprene; C082360:fipronil